LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)

Filter results: >>>>
Cell Small Molecule Small Mol Concentration (uM) Time Point (hr) Total Cell Count Before Treatment Total Cell Count After Treatment Total Control Cell Count Relative Cell Count Normalized Growth Rate Inhibition Value Assay Plate Assay Well
MCF 10A-H2B-mCherry Trametinib
0.01
27.49 27.76 1100 1723 0.6384 0.8548
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
29.19 27.76 983 1863 0.5276 0.8000
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
29.19 27.76 1037 1863 0.5566 0.8159
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
29.19 27.76 140 1863 0.0751 0.3056
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
29.19 27.76 1122 1863 0.6022 0.8397
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
30.90 27.76 1020 2032 0.5019 0.7893
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
30.90 27.76 1066 2032 0.5245 0.8021
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
30.90 27.76 153 2032 0.0753 0.3173
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
30.90 27.76 1010 2032 0.4970 0.7865
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
32.60 27.76 1037 2235 0.4638 0.7715
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
32.60 27.76 1082 2235 0.4839 0.7834
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
32.60 27.76 186 2235 0.0832 0.3504
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
32.60 27.76 1150 2235 0.5143 0.8006
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
34.30 27.76 1070 2449 0.4368 0.7594
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
34.30 27.76 1108 2449 0.4523 0.7690
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
34.30 27.76 195 2449 0.0796 0.3520
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
34.30 27.76 1044 2449 0.4262 0.7528
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
36.01 27.76 1083 2662 0.4067 0.7446
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
36.01 27.76 1113 2662 0.4180 0.7518
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
36.01 27.76 224 2662 0.0841 0.3732
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
36.01 27.76 1336 2662 0.5017 0.8011
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
37.71 27.76 1108 2877 0.3850 0.7343
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
37.71 27.76 1133 2877 0.3937 0.7401
MN20160318_Q01
H06
MCF 10A-H2B-mCherry Trametinib
0.01
37.71 27.76 221 2877 0.0768 0.3632
MN20160318_Q01
M14
MCF 10A-H2B-mCherry Trametinib
0.01
37.71 27.76 1413 2877 0.4910 0.7985
MN20160318_Q01
M14